Inovio Pharmaceuticals Prices $17.5 Million Public Offering

MT Newswires Live04-02

Inovio Pharmaceuticals (INO) said Thursday that it has priced an underwritten public offering of 12.5 million shares, Series A warrants to buy up to 12.5 million shares, and Series B warrants to buy up to 12.5 million shares at a combined price of $1.40 per share and Series A and Series B warrants, for expected gross proceeds of $17.5 million.

The underwriter was given an option for a 30-day period to buy up to 1.875 million additional shares of the company's common stock, Series A warrants to buy up to 1.875 million additional shares, and Series B warrants to buy up to 1.875 million additional shares, Inovio said.

The offering is expected to be completed on or about April 6, the company said.

Price: 1.19, Change: -0.56, Percent Change: -31.90

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2624504047?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2624504047","market":"hk","top_or_hot":-1,"title":"Inovio Pharmaceuticals Prices $17.5 Million Public Offering","media":"MT Newswires Live","content":"<html><body><p> Inovio Pharmaceuticals (INO) said Thursday that it has priced an underwritten public offering of 12.5 million shares, Series A warrants to buy up to 12.5 million shares, and Series B warrants to buy up to 12.5 million shares at a combined price of $1.40 per share and Series A and Series B warrants, for expected gross proceeds of $17.5 million.</p><p>The underwriter was given an option for a 30-day period to buy up to 1.875 million additional shares of the company's common stock, Series A warrants to buy up to 1.875 million additional shares, and Series B warrants to buy up to 1.875 million additional shares, Inovio said.</p><p>The offering is expected to be completed on or about April 6, the company said.</p><p>Price: 1.19, Change: -0.56, Percent Change: -31.90</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inovio Pharmaceuticals Prices $17.5 Million Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInovio Pharmaceuticals Prices $17.5 Million Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-02 21:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Inovio Pharmaceuticals (INO) said Thursday that it has priced an underwritten public offering of 12.5 million shares, Series A warrants to buy up to 12.5 million shares, and Series B warrants to buy up to 12.5 million shares at a combined price of $1.40 per share and Series A and Series B warrants, for expected gross proceeds of $17.5 million.</p><p>The underwriter was given an option for a 30-day period to buy up to 1.875 million additional shares of the company's common stock, Series A warrants to buy up to 1.875 million additional shares, and Series B warrants to buy up to 1.875 million additional shares, Inovio said.</p><p>The offering is expected to be completed on or about April 6, the company said.</p><p>Price: 1.19, Change: -0.56, Percent Change: -31.90</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4568","symbol_name":"美国抗疫概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2624504047","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2624504047","pubTimestamp":1775137455,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Inovio Pharmaceuticals  said Thursday that it has priced an underwritten public offering of 12.5 million shares, Series A warrants to buy up to 12.5 million shares, and Series B warrants to buy up to 12.5 million shares at a combined price of $1.40 per share and Series A and Series B warrants, for expected gross proceeds of $17.5 million.The underwriter was given an option for a 30-day period to buy up to 1.875 million additional shares of the company's common stock, Series A warrants to buy up to 1.875 million additional shares, and Series B warrants to buy up to 1.875 million additional shares, Inovio said.The offering is expected to be completed on or about April 6, the company said.Price: 1.19, Change: -0.56, Percent Change: -31.90","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4568":"美国抗疫概念","INO":"伊诺维奥制药","BK4583":"猴痘概念","BK4139":"生物科技"},"translate_title":"Inovio Pharmaceuticals公开发行定价1750万美元","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INO":1.5},"content_text":"Inovio Pharmaceuticals (INO) said Thursday that it has priced an underwritten public offering of 12.5 million shares, Series A warrants to buy up to 12.5 million shares, and Series B warrants to buy up to 12.5 million shares at a combined price of $1.40 per share and Series A and Series B warrants, for expected gross proceeds of $17.5 million.The underwriter was given an option for a 30-day period to buy up to 1.875 million additional shares of the company's common stock, Series A warrants to buy up to 1.875 million additional shares, and Series B warrants to buy up to 1.875 million additional shares, Inovio said.The offering is expected to be completed on or about April 6, the company said.Price: 1.19, Change: -0.56, Percent Change: -31.90","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2624504047","isCrawlerRequest":true}